Business
3D Systems Advances Regenerative Medical Solutions for First-of-its-Kind Peripheral Nerve Repair
Collaboration with French MedTech company, TISSIUM, has resulted in FDA approval for unique 3D-printed polymeric solution for repair of peripheral nerve damage3D Systems’ bioprinting system enabled production of a 3D-printed bioabsorbable medical device leveraging TISSIUM’s proprietary biomorphic programable polymers—a major industry milestone that sets new standard for high resolution elastomeric 3D-printed medical implantsBuilds on 3D Systems’ pioneering work to develop additive manufacturing
About this update from 3d Systems Corporation
[{"type":"image","alt":"3D Systems Inc.","displaySize":"","headline":null,"caption":"3D Systems Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":47,"url":"https://media.zenfs.com/en/globenewswire.com/f1bfb1a6105992167fd7ce4b17d83d5d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/UGlOLG8EAmbbluvYT2312g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTY2O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/f1bfb1a6105992167fd7ce4b17d83d5d","width":300,"height":47}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Collaboration with French MedTech company, TISSIUM, has resulted in FDA approval for unique 3D-printed polymeric solution for repair of peripheral nerve damage","length":159,"tagName":"p"}]},{"val":[{"type":"text","content":"3D Systems’ bioprinting system enabled production of a 3D-printed bioabsorbable medical device leveraging TISSIUM’s proprietary biomorphic programable polymers—a major industry milestone that sets new standard for high resolution elastomeric 3D-printed medical implants","length":269,"tagName":"p"}]},{"val":[{"type":"text","content":"Builds on 3D Systems’ pioneering work to develop additive manufacturing solutions for regenerative medicine applications","length":120,"tagName":"p"}]},{"val":[{"type":"text","content":"3D Systems’ solutions accelerating additive manufacturing use in bioprinting—total market anticipated to reach more than $2 billion by end of 2029","length":146,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":694,"olType":false},{"type":"text","content":"ROCK HILL, South Carolina, June 26, 2025 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE: DDD) announced that its 3D bioprinting technologies have enabled FDA approval for the regenerative repair of peripheral nerve damage. For the last several years, 3D Systems has partnered with TISSIUM, a French MedTech company that is a pioneer in the development of biomorphic programmable polymers for tissue reconstruction, to develop a bespoke 3D printing solution for the repair of damaged peripheral nerves. Combining TISSIUM’s expertise and proprietary biomorphic programable polymers with 3D Systems’ ground-breaking regenerative medicine bioprinting technologies has resulted in the successful development of a fully bioabsorbable 3D-printed medical device for nerve repair utilizing a unique photopolymer. Th...